BridgeBio Pharma, Inc. (MUN:2CL)
62.18
+7.98 (14.72%)
At close: Dec 1, 2025
BridgeBio Pharma Employees
As of December 31, 2024, BridgeBio Pharma had 730 total employees, including 725 full-time and 5 part-time employees. The number of employees increased by 174 or 31.29% compared to the previous year.
Employees
730
Change (1Y)
174
Growth (1Y)
31.29%
Revenue / Employee
€414,185
Profits / Employee
€933,219
Market Cap
12.53B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 730 | 174 | 31.29% | 725 | 5 |
| Dec 31, 2023 | 556 | 160 | 40.40% | 550 | 6 |
| Dec 31, 2022 | 396 | -182 | -31.49% | 392 | 4 |
| Dec 31, 2021 | 578 | 182 | 45.96% | 576 | 2 |
| Dec 31, 2020 | 396 | 148 | 59.68% | 385 | 11 |
| Sep 30, 2020 | 369 | 159 | 75.71% | 369 | 0 |
| Jun 30, 2020 | 328 | 143 | 77.30% | 328 | 0 |
| Mar 31, 2020 | 296 | 144 | 94.74% | 296 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
Employee RankingsBridgeBio Pharma News
- 12 days ago - Wells Fargo Raises Price Target on BBIO, Maintains Overweight Rating | BBIO Stock News - GuruFocus
- 16 days ago - Pre-Market Most Active for Jan 16, 2026 : IBRX, TQQQ, TSLL, BBIO, NVO, T, MU, RKLZ, QXO, NOK, SMR, RDW - Nasdaq
- 16 days ago - BridgeBio Pharma prices $550M convertible bond offering - Seeking Alpha
- 16 days ago - BridgeBio Pharma Prices $550 Mln Of 0.75% Convertible Senior Notes Due 2033 - Nasdaq
- 16 days ago - BridgeBio Prices Offering of $550 Million Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027 - GlobeNewsWire
- 17 days ago - BridgeBio Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027 - GlobeNewsWire
- 19 days ago - BridgeBio Pharma Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
- 19 days ago - BridgeBio Pharma, Inc. (BBIO) Presents at 44th Annual J.P. Morgan Healthcare Conference Prepared Remarks Transcript - Seeking Alpha